Choosing CCR5 or Rev siRNA in HIV-1

被引：27
|
作者：
Arteaga, HJ [1 ]
Hinkula, J
van Dijk-Härd, I
Dilber, MS
Wahren, B
Christensson, B
Mohamed, AJ
Smith, CIE
机构：
[1] Huddinge Univ Hosp, Dept Med, Karolinska Inst, SE-14186 Huddinge, Sweden
[2] Huddinge Univ Hosp, Dept Immunol Microbiol & Pathol, Karolinska Inst, SE-14186 Huddinge, Sweden
[3] Inst Infect Dis Control, Dept Virol, Stockholm, Sweden
[4] Malmo Univ, Dept Hlth & Soc, Malmo, Sweden
[5] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden
[6] Univ Coll S Stockholm, Stockholm, Sweden
[7] Karolinska Inst, Clin Res Ctr, Novum, SE-14186 Huddinge, Sweden
来源：
NATURE BIOTECHNOLOGY | 2003年 / 21卷 / 03期
关键词：
D O I：
10.1038/nbt0303-230
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：230 / 231
页数：3
相关论文
共 50 条
  • [1] Choosing CCR5 or Rev siRNA in HIV-1
    H. Jose Arteaga
    Jorma Hinkula
    Iris van Dijk-Härd
    M. Sirac Dilber
    Britta Wahren
    Birger Christensson
    Abdalla J. Mohamed
    C. I. Edvard Smith
    [J]. Nature Biotechnology, 2003, 21 : 230 - 231
  • [2] Efficient inhibition of HIV-1 infection by plasmid-encoded siRNA against CCR5 and rev transcripts
    Arteaga, JH
    Himkula, J
    van Dijk-Härd, IF
    Dilber, SM
    Wahren, B
    Christensson, B
    Mohamed, AJ
    Smith, ECI
    [J]. MOLECULAR THERAPY, 2003, 7 (05) : S303 - S303
  • [3] CCR5 HIV-1 vertical transmission
    Shearer, WT
    Kalish, LA
    Zimmerman, PA
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (02): : 180 - 181
  • [4] CCR5 inhibitors in HIV-1 therapy
    Dorr, Patrick
    Perros, Manos
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (11) : 1345 - 1361
  • [5] Inhibiting HIV-1 infection in human T-cells by lentiviral-mediated delivery of siRNA against CCR5 and Rev
    An, DS
    Qin, XF
    Baltimore, D
    Chen, ISY
    [J]. MOLECULAR THERAPY, 2003, 7 (05) : S149 - S149
  • [6] CCR5 monoclonal antibodies for HIV-1 therapy
    Olson, William C.
    Jacobson, Jeffrey M.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2009, 4 (02) : 104 - 111
  • [7] HIV-1 infection and CCR5Δ32 homozygosis
    Ballana, Ester
    Este, Jose A.
    [J]. FUTURE VIROLOGY, 2012, 7 (07) : 653 - 658
  • [8] CCR5 as target for HIV-1 gene therapy
    Nazari, Reza
    Joshi, Sadhna
    [J]. CURRENT GENE THERAPY, 2008, 8 (04) : 264 - 272
  • [9] CCR5Δ32及CCR5 siRNA共修饰的树突状细胞抗HIV-1的初步研究
    夏承来
    李书华
    [J]. 中国医学前沿杂志(电子版), 2014, 6 (09) : 19 - 22
  • [10] CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
    Oh, Djin-Ye
    Jessen, Heiko
    Kuecherer, Claudia
    Neumann, Konrad
    Oh, Nari
    Poggensee, Gabriele
    Bartmeyer, Barbara
    Jessen, Arne
    Pruss, Axel
    Schumann, Ralf R.
    Hamouda, Osamah
    [J]. PLOS ONE, 2008, 3 (07):
12345